Holocene Advisors
AKRO

Holocene Advisors’s Akero Therapeutics AKRO Stock Holding History

Holocene Advisors’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-612,000
Closed -$14.3M – 697
2023
Q4 		$14.3M Buy
612,000
+25,700
+4% +$507K 0.06% 242
2023
Q3 		$29.7M Buy
+586,300
New +$27.3M 0.13% 186

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Holocene Advisors's AKRO Position: Q4 2025 in Review

Holocene Advisors sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 1,055,186 shares — an estimated $50.1M sold.

Holocene Advisors first reported a position in AKRO in Q3 2023 and held it in 3 quarters. The position peaked at $57.4M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Holocene Advisors reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Holocene Advisors sold 1,055,186 Akero Therapeutics shares in Q4 2025, an estimated $50.1M.
  • Holocene Advisors first reported a position in Akero Therapeutics in Q3 2023 and held it in 3 quarters.
  • Holocene Advisors's Akero Therapeutics position peaked at $57.4M in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Holocene Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.